COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study.
Allsup, David Howard, Dena Emmerson, Jake Hockaday, Anna Rawstron, Andy Oughton, Jamie B Bloor, Adrian Phillips, David Nathwani, Amit Paneesha, Shankara
Allsup, David
Howard, Dena
Emmerson, Jake
Hockaday, Anna
Rawstron, Andy
Oughton, Jamie B
Bloor, Adrian
Phillips, David
Nathwani, Amit
Paneesha, Shankara
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2021-05-24
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Allsup D, Howard D, Emmerson J, Hockaday A, Rawstron A, Oughton JB, Bloor A, Phillips D, Nathwani A, Paneesha S, Turner D, Munir T, Hillmen P. COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study. Br J Haematol. 2021 Aug;194(3):646-650. doi: 10.1111/bjh.17526. Epub 2021 May 24
Type
Article